Results 221 to 230 of about 1,319,694 (261)
Some of the next articles are maybe not open access.
Molecular markers in pituitary tumors
Current Opinion in Endocrinology, Diabetes & Obesity, 2016Purpose of review This review summarizes our current understanding of the mechanisms and factors involved in pituitary tumorigenesis. It provides a comprehensive review on the role of genetic mutations, epigenetics, oncogenes, tumor suppressor genes, cell cycle deregulation, and highlights recent findings of altered micro-RNA ...
Asha M, Robertson, Anthony P, Heaney
openaire +2 more sources
DCIS: Pathology and Molecular Markers
2006Ductal carcinoma in situ (DCIS) represents a proliferation of malignant epithelial cells within the ducts of the breast, without invasion through the basement membrane. It is assumed that all invasive carcinomas of the breast are preceded by DCIS; however, it is not known what proportion of DCIS, if left untreated, will progress to invasive carcinoma ...
Meijnen, Philip +2 more
openaire +2 more sources
A MOLECULAR MARKER MAP FOR ROSES
Acta Horticulturae, 2001n addition to an existing core map for diploid roses which comprised 305 molecular markers 60 additional markers were mapped to extend the map. As a first application of the information contained in the map, the map position of a resistance gene from roses, Rdr1, was determined by identifying closely linked markers on linkage group 1.
Debener, T., Mattiesch, L., Vosman, B.
openaire +1 more source
Molecular markers for diagnosis and prognosis
Cancer and Metastasis Reviews, 2005A plethora of aberrations are associated with progress and outcome for head and neck cancer patients and some have been shown to provide prognostic information independent of the TNM staging system. These findings justify future studies that will harness recent advances in technologies to refine the range of molecular markers available.
Partridge, M, Gaballah, K, Huang, X
openaire +3 more sources
Molecular markers in cervical cytology
Clinics in Laboratory Medicine, 2003It is expected that in the near future, the high sensitivity of array-based technologies and identification of panels of molecular fingerprints that are specific for each disease process will allow the pathologist to analyze cytologic samples and tissue biopsies by these technologies in conjunction with morphologic evaluation.
openaire +2 more sources